Received Sep 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMAB056A | — |
Expired dose administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 2-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMAB056A, expiry date 21-AUG-2025) for prophylaxis. On 03-SEP-2025, the patient received Menveo. On 03-SEP-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Expired dose administered). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 03-SEP-2025 The patient received a vaccine that was expired it was the Menveo 2-vial presentation. The reporter consented to follow up.